These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30972581)

  • 1. Caudate volume differences among treatment responders, non-responders and controls in children with obsessive-compulsive disorder.
    Vattimo EFQ; Barros VB; Requena G; Sato JR; Fatori D; Miguel EC; Shavitt RG; Hoexter MQ; Batistuzzo MC
    Eur Child Adolesc Psychiatry; 2019 Dec; 28(12):1607-1617. PubMed ID: 30972581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial.
    Hoexter MQ; de Souza Duran FL; D'Alcante CC; Dougherty DD; Shavitt RG; Lopes AC; Diniz JB; Deckersbach T; Batistuzzo MC; Bressan RA; Miguel EC; Busatto GF
    Neuropsychopharmacology; 2012 Feb; 37(3):734-45. PubMed ID: 22030709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive-compulsive disorder.
    Hoexter MQ; Dougherty DD; Shavitt RG; D'Alcante CC; Duran FL; Lopes AC; Diniz JB; Batistuzzo MC; Evans KC; Bressan RA; Busatto GF; Miguel EC
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):569-80. PubMed ID: 22841131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortico-striato-thalamo-cortical circuit abnormalities in obsessive-compulsive disorder: A voxel-based morphometric and fMRI study of the whole brain.
    Tang W; Zhu Q; Gong X; Zhu C; Wang Y; Chen S
    Behav Brain Res; 2016 Oct; 313():17-22. PubMed ID: 27388149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Structural Correlates of Subclinical Obsessive-Compulsive Symptoms in Healthy Children.
    Suñol M; Contreras-Rodríguez O; Macià D; Martínez-Vilavella G; Martínez-Zalacaín I; Subirà M; Pujol J; Sunyer J; Soriano-Mas C
    J Am Acad Child Adolesc Psychiatry; 2018 Jan; 57(1):41-47. PubMed ID: 29301668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric brain characterization of refractory obsessive-compulsive disorder: diffeomorphic anatomic registration using exponentiated Lie algebra.
    Tang W; Li B; Huang X; Jiang X; Li F; Wang L; Chen T; Wang J; Gong Q; Yang Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():126-31. PubMed ID: 23876787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter structural alterations in pediatric obsessive-compulsive disorder: relation to symptom dimensions.
    Lázaro L; Ortiz AG; Calvo A; Ortiz AE; Moreno E; Morer A; Calvo R; Bargallo N
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():249-58. PubMed ID: 24977330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological heterogeneity of obsessive-compulsive disorder: A voxel-based morphometric study based on dimensional assessment.
    Okada K; Nakao T; Sanematsu H; Murayama K; Honda S; Tomita M; Togao O; Yoshiura T; Kanba S
    Psychiatry Clin Neurosci; 2015 Jul; 69(7):411-21. PubMed ID: 25556718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural brain abnormalities correlate with clinical features in patients with drug-naïve OCD: A DARTEL-enhanced voxel-based morphometry study.
    Tang W; Huang X; Li B; Jiang X; Li F; Xu J; Yang Y; Gong Q
    Behav Brain Res; 2015 Nov; 294():72-80. PubMed ID: 26241173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of caudate volume in drug-naïve adult patients with obsessive-compulsive disorder.
    Narayanaswamy JC; Jose DA; Kalmady SV; Venkatasubramanian G; Janardhana Reddy YC
    Psychiatry Res; 2013 Apr; 212(1):7-13. PubMed ID: 23489673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems.
    van den Heuvel OA; Remijnse PL; Mataix-Cols D; Vrenken H; Groenewegen HJ; Uylings HB; van Balkom AJ; Veltman DJ
    Brain; 2009 Apr; 132(Pt 4):853-68. PubMed ID: 18952675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder.
    Huyser C; van den Heuvel OA; Wolters LH; de Haan E; Boer F; Veltman DJ
    World J Biol Psychiatry; 2013 May; 14(4):319-31. PubMed ID: 22746998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caudate gray matter volume in obsessive-compulsive disorder is influenced by adverse childhood experiences and ongoing drug treatment.
    Benedetti F; Poletti S; Radaelli D; Pozzi E; Giacosa C; Ruffini C; Falini A; Smeraldi E
    J Clin Psychopharmacol; 2012 Aug; 32(4):544-7. PubMed ID: 22722505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of white matter microstructure in unmedicated patients with obsessive-compulsive disorder: Changes after cognitive behavioral therapy.
    Zhong Z; Yang X; Cao R; Li P; Li Z; Lv L; Zhang D
    Brain Behav; 2019 Feb; 9(2):e01201. PubMed ID: 30623612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Outcome for Responders of Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder.
    Højgaard DRMA; Hybel KA; Ivarsson T; Skarphedinsson G; Becker Nissen J; Weidle B; Melin K; Torp NC; Valderhaug R; Dahl K; Mortensen EL; Compton S; Jensen S; Lenhard F; Thomsen PH
    J Am Acad Child Adolesc Psychiatry; 2017 Nov; 56(11):940-947.e1. PubMed ID: 29096776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate in Pediatric Obsessive-Compulsive Disorder and Response to Cognitive-Behavioral Therapy: Randomized Clinical Trial.
    O'Neill J; Piacentini J; Chang S; Ly R; Lai TM; Armstrong CC; Bergman L; Rozenman M; Peris T; Vreeland A; Mudgway R; Levitt JG; Salamon N; Posse S; Hellemann GS; Alger JR; McCracken JT; Nurmi EL
    Neuropsychopharmacology; 2017 Nov; 42(12):2414-2422. PubMed ID: 28409563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased gray matter volume and dynamic functional alterations in medicine-free obsessive-compulsive disorder.
    Ding Z; Ding Z; Chen Y; Lv D; Li T; Shang T; Ma J; Zhan C; Yang X; Xiao J; Sun Z; Wang N; Guo W; Li C; Yu Z; Li P
    BMC Psychiatry; 2023 Apr; 23(1):289. PubMed ID: 37098479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of cognitive-coping therapy and alteration of resting-state brain function in obsessive-compulsive disorder.
    Zhao HZ; Wang CH; Gao ZZ; Ma JD; Huang P; Li HF; Sang DE; Shan XW; Kou SJ; Li ZR; Ma L; Zhang ZH; Zhang JH; Ouyang H; Lian HK; Zang YF; Hu XZ
    J Affect Disord; 2017 Jan; 208():184-190. PubMed ID: 27792961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-brain volume alteration and its correlation with anxiety severity in patients with obsessive-compulsive disorder and generalized anxiety disorder.
    Kim GW; Yoon W; Jeong GW
    Clin Imaging; 2018; 50():164-170. PubMed ID: 29567629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.